Cargando…

The nSMase2/Smpd3 gene modulates the severity of muscular dystrophy and the emotional stress response in mdx mice

BACKGROUND: Duchenne muscular dystrophy (DMD) is a progressive, degenerative muscular disorder and cognitive dysfunction caused by mutations in the dystrophin gene. It is characterized by excess inflammatory responses in the muscle and repeated degeneration and regeneration cycles. Neutral sphingomy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuzaka, Yasunari, Tanihata, Jun, Ooshima, Yoshiko, Yamada, Daisuke, Sekiguchi, Masayuki, Miyatake, Shouta, Aoki, Yoshitsugu, Terumitsu, Mika, Yashiro, Ryu, Komaki, Hirofumi, Ishiyama, Akihiko, Oya, Yasushi, Inoue, Yukiko U., Inoue, Takayoshi, Takeda, Shin’ichi, Hashido, Kazuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677854/ https://www.ncbi.nlm.nih.gov/pubmed/33208172 http://dx.doi.org/10.1186/s12916-020-01805-5

Ejemplares similares

Therapeutic Application of Extracellular Vesicles-Capsulated Adeno-Associated Virus Vector via nSMase2/Smpd3, Satellite, and Immune Cells in Duchenne Muscular Dystrophy
por: Matsuzaka, Yasunari, et al.
Publicado: (2022)

Characterization and Functional Analysis of Extracellular Vesicles and Muscle-Abundant miRNAs (miR-1, miR-133a, and miR-206) in C(2)C(12) Myocytes and mdx Mice
por: Matsuzaka, Yasunari, et al.
Publicado: (2016)

Dendrimer-Conjugated nSMase2 Inhibitor Reduces Tau Propagation in Mice
por: Tallon, Carolyn, et al.
Publicado: (2022)

Inhibition of nSMase2 Reduces the Transfer of Oligomeric α-Synuclein Irrespective of Hypoxia
por: Sackmann, Valerie, et al.
Publicado: (2019)

Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nSMase1 by JNK signaling
por: Yabu, T, et al.
Publicado: (2015)

Microglial-Targeted nSMase2 Inhibitor Fails to Reduce Tau Propagation in PS19 Mice
por: Huang, Meixiang, et al.
Publicado: (2023)

Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in murine Alzheimer’s disease
por: Tallon, Carolyn, et al.
Publicado: (2023)

Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model
por: Tallon, Carolyn, et al.
Publicado: (2023)

The Expression of PHOSPHO1, nSMase2 and TNAP is Coordinately Regulated by Continuous PTH Exposure in Mineralising Osteoblast Cultures
por: Houston, D. A., et al.
Publicado: (2016)

Neutral Sphingomyelinase 2 (nSMase2)-dependent Exosomal Transfer of Angiogenic MicroRNAs Regulate Cancer Cell Metastasis
por: Kosaka, Nobuyoshi, et al.
Publicado: (2013)

nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe(−/−) Mice
por: Lallemand, Tom, et al.
Publicado: (2018)

Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model
por: Zhu, Chunni, et al.
Publicado: (2021)

Early activation of nSMase2/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampi
por: Gu, LiZe, et al.
Publicado: (2013)

Correction to: Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model
por: Zhu, Chunni, et al.
Publicado: (2021)

Allosteric Inhibition of Neutral Sphingomyelinase 2 (nSMase2) by DPTIP: From Antiflaviviral Activity to Deciphering Its Binding Site through In Silico Studies and Experimental Validation
por: Álvarez-Fernández, Hadrián, et al.
Publicado: (2022)

Inhibiting Extracellular Vesicle Release from Human Cardiosphere Derived Cells with Lentiviral Knockdown of nSMase2 Differentially Effects Proliferation and Apoptosis in Cardiomyocytes, Fibroblasts and Endothelial Cells In Vitro
por: Lang, Jennifer K., et al.
Publicado: (2016)

Mutation Types and Aging Differently Affect Revertant Fiber Expansion in Dystrophic Mdx and Mdx52 Mice
por: Echigoya, Yusuke, et al.
Publicado: (2013)

Transcriptome analysis of intestine from alk-SMase knockout mice reveals the effect of alk-SMase
por: Zhu, Jiang, et al.
Publicado: (2022)

Correction: Transcriptome analysis of intestine from alk-SMase knockout mice reveals the effect of alk-SMase
por: Zhu, Jiang, et al.
Publicado: (2022)

Immune Modulation Using Extracellular Vesicles Encapsulated with MicroRNAs as Novel Drug Delivery Systems
por: Matsuzaka, Yasunari, et al.
Publicado: (2022)

Therapeutic Strategy of Mesenchymal-Stem-Cell-Derived Extracellular Vesicles as Regenerative Medicine
por: Matsuzaka, Yasunari, et al.
Publicado: (2022)

Extracellular Vesicles as Novel Drug-Delivery Systems through Intracellular Communications
por: Matsuzaka, Yasunari, et al.
Publicado: (2022)

Regulation of Extracellular Vesicle-Mediated Immune Responses against Antigen-Specific Presentation
por: Matsuzaka, Yasunari, et al.
Publicado: (2022)

Advances in Purification, Modification, and Application of Extracellular Vesicles for Novel Clinical Treatments
por: Matsuzaka, Yasunari, et al.
Publicado: (2022)

Molecular Docking and Intracellular Translocation of Extracellular Vesicles for Efficient Drug Delivery
por: Matsuzaka, Yasunari, et al.
Publicado: (2022)

Extracellular Vesicle-Based SARS-CoV-2 Vaccine
por: Matsuzaka, Yasunari, et al.
Publicado: (2023)

Development, Safety, Issues, and Challenges of the SARS-CoV-2 Vaccine
por: Matsuzaka, Yasunari, et al.
Publicado: (2023)

Alternative Splicing of SMPD1 in Human Sepsis
por: Kramer, Marcel, et al.
Publicado: (2015)

Long-Term Efficacy of Systemic Multiexon Skipping Targeting Dystrophin Exons 45–55 With a Cocktail of Vivo-Morpholinos in Mdx52 Mice
por: Echigoya, Yusuke, et al.
Publicado: (2015)

SMPD1 gene variants in patients with β-Thalassemia major
por: Dursun, Fadime Ersoy, et al.
Publicado: (2023)

Case report: The spectrum of SMPD1 pathogenic variants in Hungary
por: Molnar, Maria Judit, et al.
Publicado: (2023)

Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors
por: Miyatake, Shouta, et al.
Publicado: (2016)

Aquaporin 4 Expression in the mdx Mouse Diaphragm
por: Hara, Hajime, et al.
Publicado: (2011)

Transcriptome analysis alk-SMase knockout mice reveals the effect of alkaline sphingomyelinase on liver
por: Zhu, Jiang, et al.
Publicado: (2022)

iNOS is not responsible for RyR1 S-nitrosylation in mdx mice with truncated dystrophin
por: Nogami, Ken’ichiro, et al.
Publicado: (2020)

Alleged Detrimental Mutations in the SMPD1 Gene in Patients with Niemann-Pick Disease
por: Rhein, Cosima, et al.
Publicado: (2015)

SMPD3 deficiency perturbs neuronal proteostasis and causes progressive cognitive impairment
por: Stoffel, Wilhelm, et al.
Publicado: (2018)

Mutational spectrum of SMPD1 gene in Pakistani Niemann-Pick disease patients
por: Cheema, Huma Arshad, et al.
Publicado: (2020)

SMPD3‐ALK: A novel ALK fusion gene in lung adenocarcinoma
por: Liang, Yuepei, et al.
Publicado: (2021)

DNA methylation of SMPD3-based diagnostic biomarkers of NASH and mild fibrosis
por: Wu, Na, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ti1nj3ohglc5pj1knqqvvpebhu